USFDA APPROVES INFLUENZA VACCINE FROM SEQIRUS
HIGHLIGHTS USFDA has approved the expanded age indication of cell-based Quadrivalent influenza vaccine for people aged two years and above. The vaccine has been developed by Seqirus. The United States Food & Drug Administration (USFDA) has approved an influenza vaccine…